Myeloid Therapeutics

Series-B+
myeloidtx.com Biotech & Healthcare Cambridge, United States Founded 2021 11-50
Total Funding $50M
Latest Round Undisclosed Series-B+
Last Announced May 14, 2026
Investors Undisclosed
Decision Makers 4 Verified

About Myeloid Therapeutics

Immunology company focused on combining biology insights with cutting-edge technologies to harness myeloid cells and eradicate cancer and other diseases.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Cambridge, United States
Year Founded 2021
Team Size 11-50
Tracked Since Sep 29, 2026

Web & Domain Identity

Official Website myeloidtx.com
Domain Registered Date Mar 7, 2019

Social & Network Presence

X / Twitter Profile @MyeloidTx (143 followers) Created on Mar 2020
LinkedIn Corporate Not linked

Company Milestones & Timeline

5 Events
  1. Capital Raise

    Series-B+ announced

    fundraisingfox.com

  2. Capital Raise

    Raised $50,000,000 · Venture Round

    BioSpace

  3. Milestone

    Company founded

    Cambridge, United States

  4. Milestone

    X account created (@MyeloidTx)

    143 followers

  5. Milestone

    Website domain registered

    myeloidtx.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Myeloid Therapeutics.

Funding History

2 Rounds
Series-B+ · May 14, 2026
Venture Round · Jan 6, 2021
$50,000,000 BioSpace

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts